Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Two Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment
↗
August 07, 2026
Via
Benzinga
Exposures
Product Safety
Top Healthcare Software Development Companies: A 2026 Guide
↗
August 07, 2026
Via
Talk Markets
Exposures
Product Safety
Roivant Sciences Q1 Earnings Call Highlights
↗
August 07, 2026
Via
MarketBeat
Topics
Earnings
Government
Tickers
ROIV
Exposures
Financial
Political
Product Safety
Relmada Therapeutics Q2 Earnings Call Highlights
↗
August 07, 2026
Via
MarketBeat
Topics
Earnings
Tickers
RLMD
Exposures
Financial
Product Safety
Ponder the Albatross Announces New Album Over Hill & Hollow and Shares the Story Behind Defining Track “1879”
August 07, 2026
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
QuidelOrtho Q2 Earnings Call Highlights
↗
August 07, 2026
Via
MarketBeat
Topics
Earnings
Tickers
QDEL
Exposures
Financial
Product Safety
Global Scientific Data Management Software Market to Reach USD 2.23 Billion by 2034, Growing at 5.1% CAGR
↗
August 07, 2026
Via
Talk Markets
Tickers
INTC
Exposures
Product Safety
Praxis Precision Medicines Q2 Earnings Call Highlights
↗
August 07, 2026
Via
MarketBeat
Topics
Earnings
Tickers
PRAX
Exposures
Financial
Product Safety
Ocugen Q2 Earnings Call Highlights
↗
August 07, 2026
Via
MarketBeat
Topics
Earnings
Tickers
ARM
OCGN
Exposures
Financial
Product Safety
Intellia Therapeutics Q2 Earnings Call Highlights
↗
August 07, 2026
Via
MarketBeat
Topics
Earnings
Intellectual Property
Tickers
ARM
NTLA
Exposures
Financial
Intellectual Property
Product Safety
Selecting an AI Companion Platform in 2026: Key Factors
August 06, 2026
Via
PulseBulletin.com
Topics
Artificial Intelligence
Product Recall
Exposures
Artificial Intelligence
Legal
Product Safety
Denali Therapeutics Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
DNLI
Exposures
Financial
Product Safety
CryoPort Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
CYRX
Exposures
Financial
Product Safety
Amphastar Pharmaceuticals Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
AMPH
Exposures
Financial
Product Safety
Apyx Medical Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
APYX
Exposures
Financial
Product Safety
Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Leadership in a Securities Fraud Lawsuit by September 28, 2026
August 06, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
BAC
CAPR
Exposures
Financial
Legal
Product Safety
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of an Investigation Into Potential Securities Law Violations
August 06, 2026
Via
NewMediaWire
Tickers
BAC
MDLN
Exposures
Product Safety
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
August 06, 2026
Via
Newsfile
Tickers
PHIO
Exposures
Product Safety
Iovance Biotherapeutics Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
IOVA
Exposures
Financial
Product Safety
Kaplan Fox Notifies Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of an Investigation Into Potential Securities Law Violations
August 06, 2026
Via
NewMediaWire
Tickers
FULC
Exposures
Product Safety
Takeda Achieves Major Milestone With Holistic Narcolepsy Drug Approval
↗
August 06, 2026
Via
Benzinga
Exposures
Product Safety
Beyond COVID: Moderna Wins FDA Approval for Its Seasonal Flu Vaccine
↗
August 06, 2026
Via
Benzinga
Exposures
Product Safety
Amylyx Pharmaceuticals Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
AMLX
Exposures
Financial
Product Safety
Crrow777 Radio 691: Addiction Recovery and Sleep, With Jeff Nunn of Project Biohacking
August 06, 2026
Via
PRUnderground
Exposures
Product Safety
Moderna Wavers Despite Hard-Fought FDA Win; Will Its Sprint Restart?
↗
August 06, 2026
Via
Investor's Business Daily
Exposures
Product Safety
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It
August 06, 2026
Via
Newsfile
Tickers
PTN
Exposures
Product Safety
What Is a Regulatory Writing Course? A Complete Beginner's Guide
↗
August 06, 2026
Via
Talk Markets
Exposures
Product Safety
Vanda Pharmaceuticals Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
VNDA
Exposures
Financial
Product Safety
Revolution Medicines Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
RVMD
Exposures
Financial
Product Safety
OraSure Technologies Q2 Earnings Call Highlights
↗
August 06, 2026
Via
MarketBeat
Topics
Earnings
Tickers
OSUR
Exposures
Financial
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today